Greenwood Village, CO1 Active Studies

Huntingtons Disease Clinical Trials in Greenwood Village, CO

Find 1 actively recruiting huntingtons disease clinical trials in Greenwood Village, CO. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
150
Enrolling

Recruiting Huntingtons Disease Studies in Greenwood Village

About Huntingtons Disease Clinical Trials in Greenwood Village

Huntington's disease is an inherited condition that causes progressive degeneration of nerve cells in the brain, affecting movement, cognition, and behavior. It is caused by a mutation in the HTT gene. Current treatments manage symptoms, while gene-silencing therapies are being studied.

There are currently 1 huntingtons disease clinical trials recruiting participants in Greenwood Village, CO. These studies are seeking a combined 150 participants. Research is being sponsored by Lumos Pharma. Clinical trial participation is free and participants receive study-related medical care at no cost.

Huntingtons Disease Clinical Trials in Greenwood Village — FAQ

Are there huntingtons disease clinical trials in Greenwood Village?

Yes, there are 1 huntingtons disease clinical trials currently recruiting in Greenwood Village, CO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Greenwood Village?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Greenwood Village research site will contact you about next steps.

Are clinical trials in Greenwood Village free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Greenwood Village studies also compensate for your time and travel.

What huntingtons disease treatments are being tested?

The 1 active trials in Greenwood Village are testing new therapies including novel drugs, biologics, and treatment approaches for huntingtons disease.

Data updated July 13, 2026 from ClinicalTrials.gov